Aryaman Capital Markets has appointed Ronak Jain as an Additional Non-Executive Independent Director for a five-year term, effective July 31, 2026. The appointment, approved by the Board of Directors at a meeting held on July 31, 2026, is subject to shareholder approval at the ensuing general meeting. This governance change coincides with the cessation of Darshit Parikh, who ceases to hold office on the same date upon completing his second consecutive term as a Non-Executive Independent Director.

The Board also reconstituted its Nomination and Remuneration Committee to reflect these changes. The restructured committee comprises Ms. Kajal Chhatwal as Chairperson, alongside Ms. Damini Baid and Mr. Ronak Jain as members. All three hold the designation of Non-Executive Independent Director.

Board Meeting Details

The Board of Directors convened on July 31, 2026, from 10:30 A.M. to 11:00 A.M. to approve these appointments and structural adjustments. The decisions were made pursuant to Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirement) Regulations, 2015.

The company confirmed that Mr. Ronak Jain is not debarred from holding director office by any order issued by SEBI or other authorities, in compliance with Stock Exchange circulars.

Director Profiles and Disclosures

Mr. Ronak Rajendra Jain brings over a decade of experience in audit, taxation, financial reporting, regulatory compliance, corporate governance, and investment banking. He serves as the Proprietor of M/s. Ronak Jain & Associates and is a Partner at M/s. SSKA & Co., Chartered Accountants. Mr. Jain holds a Bachelor's degree in Commerce and is a Certified Information Systems Auditor (CISA). He is registered with the Independent Director Databank maintained by the Indian Institute of Corporate Affairs (IICA).

Disclosures indicate that Mr. Jain is not related to any existing Directors of the Company. He holds an interest in Escorp Asset Management Limited.

Committee Composition

The reconstituted Nomination and Remuneration Committee is structured as follows:

Regulatory Compliance

The disclosures regarding the appointment and cessation were furnished in accordance with Regulation 30 read with Paragraph A of Part A of Schedule III of the SEBI Listing Regulations. The company also cited compliance with SEBI Circular No. SEBI/HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.

Reenal Khandelwal, Company Secretary and Compliance Officer, signed the disclosure documents submitted to BSE Limited.

Aryaman Capital Markets Limited announced its audited standalone financial results for the quarter and year ended March 31, 2026. The Board of Directors approved the results during a meeting held on May 18, 2026. The company reported a net profit of ₹2,779.35 lakh for FY26, marking a 21% increase compared to ₹2,293.11 lakh in the previous year, reflecting improved profitability despite a decline in total income.

Financial Performance

For the quarter ended March 31, 2026, the company recorded a net profit of 43M rupees, compared to 53M rupees in the same quarter of the prior year. Q4 revenue stood at 76M rupees, against 257M rupees in the year-ago period. Total income for the quarter stood at ₹806.51 lakh, while revenue from operations was ₹768.59 lakh. For the full year, total income decreased to ₹6,156.78 lakh from ₹7,733.62 lakh in the prior year, primarily due to lower revenue from operations which fell to ₹5,908.13 lakh from ₹7,459.11 lakh. However, a significant reduction in total expenses — from ₹5,040.08 lakh to ₹2,842.61 lakh — supported the improvement in net profitability.

The following table summarises key financial metrics across periods:

Balance Sheet Highlights

As of March 31, 2026, the company's total assets stood at ₹11,813.19 lakh, compared to ₹11,610.98 lakh in the previous year. Investments rose significantly to ₹8,246.67 lakh from ₹4,704.97 lakh, while cash and cash equivalents declined to ₹2,510.00 lakh from ₹5,006.69 lakh. Inventories (Stock in Trade) were nil as of March 31, 2026, compared to ₹1,573.54 lakh in the prior year. On the liabilities side, borrowings were fully repaid, reducing to nil from ₹2,801.72 lakh, and other equity increased to ₹9,613.31 lakh from ₹6,540.51 lakh.

Cash Flow Summary

For the year ended March 31, 2026, the company generated net cash flow from operating activities of ₹3,376.14 lakh, up from ₹2,787.96 lakh in the prior year, driven by higher operating profit and a reduction in inventories. Net cash used in investing activities was ₹2,980.64 lakh, largely on account of net investment purchases of ₹3,199.47 lakh. Financing activities resulted in a net outflow of ₹2,892.19 lakh, primarily due to full repayment of borrowings of ₹2,801.72 lakh. The net cash flow during the period was ₹(2,496.68) lakh, bringing closing cash and cash equivalents to ₹2,510.00 lakh from an opening balance of ₹5,006.69 lakh.

Board Decisions

In addition to the financial results, the board approved several key decisions. Mr. Shreyas Shah was appointed as Designated Director pursuant to the provisions of the Prevention of Money-Laundering Act, 2002. M/s. KKM & Associates, Chartered Accountants (Firm Registration Number 016971S, based in Mumbai), was appointed as the Internal Auditor of the company for FY 2026-27 and FY 2027-28, effective May 18, 2026, in compliance with Section 138 of the Companies Act, 2013. The auditor's report for the financial results carries an unmodified opinion, as confirmed by the Company Secretary and Compliance Officer. The trading window for dealing in the company's securities will reopen 48 hours after the outcome of the board meeting is declared to the stock exchanges.